From these data, we hypothesized that naïve T cells co-cultured with Gal1 and Gal1–Gal2 treated DCs have acquired mixed anti-inflammatory and pro-inflammatory phenotypes similar to what has been recently described in the context of some inflammatory conditions and cancers [39]. This evidence concerns the gene GAL and cancer.